Preclinical Studies on the Broad-Spectrum Neuropeptide Growth Factor Antagonist G

Author： Jones D.A.   Cummings J.   Langdon S.P.   Smyth J.F.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.28, Iss.2, 1997-02, pp. : 183-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 8, 2016-05 ,pp. : 644-650

Bentham Science Publishers

Access to resources Recommend Favorite

Fluoxetine: broad-spectrum effect in PTSD

By  

Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Tailoring an Antibacterial Peptide of Human Lysosomal Cathepsin G to Enhance its Broad-Spectrum Action Against Antibiotic-Resistant Bacterial Pathogens

By  

Current Pharmaceutical Design, Vol. 8, Iss. 9, 2002-04 ,pp. : 695-702

Bentham Science Publishers

Access to resources Recommend Favorite

Broad-spectrum rifaximin broadens its horizons

By  

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Broad-spectrum antibacterial prescribing high in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 400, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite